Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: A new perspective for an old disease

被引:16
作者
Patriti, A [1 ]
Facchiano, E [1 ]
Donini, A [1 ]
机构
[1] Univ Perugia, I-06100 Perugia, Italy
关键词
D O I
10.1097/01.sla.0000134632.08789.df
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:388 / 389
页数:2
相关论文
共 19 条
[1]  
DEMARIA EJ, ANN SURG, V4235, P640
[2]   Glucagon-like peptide-1 synthetic analogs: New therapeutic agents for use in the treatment of diabetes mellitus [J].
Holz, GG ;
Chepurny, OG .
CURRENT MEDICINAL CHEMISTRY, 2003, 10 (22) :2471-2483
[3]   GASTROINTESTINAL HORMONE RESPONSES TO MEALS BEFORE AND AFTER GASTRIC BYPASS AND VERTICAL BANDED GASTROPLASTY [J].
KELLUM, JM ;
KUEMMERLE, JF ;
ODORISIO, TM ;
RAYFORD, P ;
MARTIN, D ;
ENGLE, K ;
WOLF, L ;
SUGERMAN, HJ .
ANNALS OF SURGERY, 1990, 211 (06) :763-771
[4]   The glucagon-like peptides [J].
Kieffer, TJ ;
Habener, JL .
ENDOCRINE REVIEWS, 1999, 20 (06) :876-913
[5]   Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus [J].
Mannucci, E ;
Ognibene, A ;
Cremasco, F ;
Bardini, G ;
Mencucci, A ;
Pierazzuoli, E ;
Ciani, S ;
Fanelli, A ;
Messeri, G ;
Rotella, CM .
DIABETIC MEDICINE, 2000, 17 (10) :713-719
[6]   Ilial transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery [J].
Mason, EE .
OBESITY SURGERY, 1999, 9 (03) :223-228
[7]   Gastric inhibitory polypeptide: the neglected incretin revisited [J].
Meier, JJ ;
Nauck, MA ;
Schmidt, WE ;
Gallwitz, B .
REGULATORY PEPTIDES, 2002, 107 (1-3) :1-13
[8]  
NAITO H, 1995, PANCREAS, V16, P370
[9]   Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity [J].
Naslund, E ;
Backman, L ;
Holst, JJ ;
Theodorsson, E ;
Hellstrom, PM .
OBESITY SURGERY, 1998, 8 (03) :253-260
[10]   REDUCED INCRETIN EFFECT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES [J].
NAUCK, M ;
STOCKMANN, F ;
EBERT, R ;
CREUTZFELDT, W .
DIABETOLOGIA, 1986, 29 (01) :46-52